Diabetes Management in Patients with Heart Failure
Diabetes and heart failure (HF) are common diseases, each affecting large segments of the world population. Moreover, prevalence rates for both are expected to rise dramatically over coming decades. The high prevalence rates of both diseases and well-recognized association of diabetes as a risk fact...
Main Authors: | Jia Shen, Barry H. Greenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2021-03-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | http://www.e-dmj.org/upload/pdf/dmj-2020-0296.pdf |
Similar Items
-
Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
by: Akshyaya Pradhan, et al.
Published: (2019-01-01) -
Different effects of SGLT2 inhibitors according to the presence and types of heart failure in type 2 diabetic patients
by: In-Chang Hwang, et al.
Published: (2020-05-01) -
Effect of sodium–glucose cotransporter 2 inhibitors on cardiac structure and function in type 2 diabetes mellitus patients with or without chronic heart failure: a meta-analysis
by: Yi-Wen Yu, et al.
Published: (2021-01-01) -
Impact of SGLT2i on cardiovascular outcomes and heart failure in patients with type 2 diabetes
by: Juan José Rodríguez, et al.
Published: (2018-01-01) -
Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
by: Fumitaka Soga, et al.
Published: (2018-10-01)